World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
68493
World Ranking
2917
National Ranking
297

Gavin Giovannoni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gavin Giovannoni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,245 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gavin Giovannoni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gavin Giovannoni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gavin Giovannoni is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily falls within the field of Medicine, with particular focus on several subfields including Pathology and Forensic Medicine, Neurology, Epidemiology, Immunology, and Molecular Biology.

The main topics covered in Giovannoni's work involve Multiple Sclerosis Research Studies, Sphingolipid Metabolism and Signaling, Polyomavirus and related diseases, Systemic Lupus Erythematosus Research, Peripheral Neuropathies and Disorders, Phytochemistry and Biological Activities, and Fungal Infections and Studies.

Giovannoni has contributed to multiple papers related to Multiple Sclerosis and neurodegenerative diseases. Selected recent publications include:

  • Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study, 2020, Journal of Neurology Neurosurgery & Psychiatry
  • Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years, 2022, Multiple Sclerosis Journal
  • Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial, 2022, Multiple Sclerosis Journal
  • Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study, 2020, Journal of Neurology
  • Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study, 2020, Multiple Sclerosis Journal

Giovannoni frequently collaborates with several researchers, including:

  • Douglas L. Arnold
  • Amit Bar-Or
  • Ralf Gold
  • Ludwig Kappos
  • Robert J. Fox

The researcher's work is published predominantly in the following venues:

  • Multiple Sclerosis Journal
  • Journal of Neurology Neurosurgery & Psychiatry
  • Revue Neurologique
  • Journal of Neurology
  • Neurology

Best Publications

  • A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

    Chris H. Polman;Eva Havrdova;Michael Hutchinson;Ludwig Kappos

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Ralf Gold;Ludwig Kappos;Douglas L Arnold;Amit Bar-Or

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Multiple Sclerosis - A Review

    R. Dobson;G. Giovannoni

  • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

    Jeffrey A. Cohen;Alasdair J. Coles;Douglas L. Arnold;Christian Confavreux

  • A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

    Sreeram V. Ramagopalan;Andreas Heger;Antonio J. Berlanga;Narelle J. Maugeri

  • A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

    Gavin Giovannoni;Giancarlo Comi;Stuart Cook;Kottil Rammohan

  • Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

    Alastair J Noyce;Jonathan P Bestwick;Laura Silveira-Moriyama;Laura Silveira-Moriyama;Christopher H Hawkes

  • A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

    Charlotte Teunissen;Axel Petzold;Jeffrey L. Bennett;Frode S. Berven

  • The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

    R. B. Banati;J. Newcombe;R. N. Gunn;A. Cagnin

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

  • Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

    David B Clifford;Andrea DeLuca;David M Simpson;Gabriele Arendt

  • Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

    G Giovannoni;J D O'Sullivan;K Turner;A J Manson

  • Multiple sclerosis: risk factors, prodromes, and potential causal pathways

    Sreeram V Ramagopalan;Ruth Dobson;Ute C Meier;Gavin Giovannoni

  • The therapeutic potential of cannabis

    David Baker;Gareth Pryce;Gavin Giovannoni;Alan J Thompson

  • Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

    Ching-Hua Lu;Corrie Macdonald-Wallis;Elizabeth Gray;Neil Pearce

  • Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

    Johanna Gaiottino;Niklas Norgren;Ruth Dobson;Joanne Topping

  • Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

    Eva Havrdova;Steven Galetta;Michael Hutchinson;Dusan Stefoski

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

Frequent Co-Authors

Eva Havrdova
Eva Havrdova Charles University
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
David Baker
David Baker University of Washington
Sreeram V. Ramagopalan
Sreeram V. Ramagopalan University of Oxford
Patrick Vermersch
Patrick Vermersch University of Lille
Ralf Gold
Ralf Gold Ruhr University Bochum
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital
Krzysztof Selmaj
Krzysztof Selmaj University of Warmia and Mazury in Olsztyn
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor. There are multiple related degrees and pathways that can open doors in healthcare, many of which now offer flexible online options. Registered nurses interested in furthering their careers can explore rn to np programs, allowing them to become nurse practitioners through streamlined bridge programs.

For those passionate about health and wellness, earning a nutrition bachelor degree online can lead to dynamic roles in dietetics, public health, or private practice. If your interest lies in the business and organizational side of healthcare, consider enrolling in accredited mha programs to gain administrative expertise required for leadership roles in hospitals and care facilities.

Additionally, working nurses seeking advanced credentials often look for flexibility. There are even rn to bsn no clinical hours programs, which enable professionals to earn their degree without additional on-site clinical requirements. These diverse online pathways provide valuable alternatives and advancement opportunities in the rapidly evolving healthcare sector.

Best Scientists Citing Gavin Giovannoni

Trending Scientists

Recently Published Articles